Data as of Apr 17
| +0.95 / +2.04%|
The 20 analysts offering 12-month price forecasts for ResMed Inc have a median target of 50.93, with a high estimate of 61.13 and a low estimate of 40.00. The median estimate represents a +7.36% increase from the last price of 47.44.
The current consensus among 23 polled investment analysts is to Hold stock in ResMed Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.